SIA
JAZZ icon

Strategic Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Strategic Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,197
Closed -$233K – 272
2025
Q2 		$233K Buy
+2,197
New +$239K 0.02% 231

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Strategic Investment Advisors's JAZZ Position: Q3 2025 in Review

Strategic Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 2,197 shares — an estimated $233K sold.

Strategic Investment Advisors first reported a position in JAZZ in Q2 2025 and held it in 1 quarter. The position peaked at $233K in Q2 2025. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Strategic Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Strategic Investment Advisors sold 2,197 Jazz Pharmaceuticals shares in Q3 2025, an estimated $233K.
  • Strategic Investment Advisors first reported a position in Jazz Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Strategic Investment Advisors's Jazz Pharmaceuticals position peaked at $233K in Q2 2025.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Strategic Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.